Because IL-1β exerts a systemic effect on immunological intolerance and plays a potential role in T1DM development, its upstream activator, the NLRP3 inflammasome, is a functionally plausible complex contributing to the pathogenesis of T1DM. This evidence concerns the gene IL1B and type 1 diabetes mellitus.